Evidence map›Paper›PMID 32998161›Full record

ArticlePloS one2020

A2A adenosine receptors are involved in the reparative response of tendon cells to pulsed electromagnetic fields.

Alessandra Colombini, Carlotta Perucca Orfei, Fabrizio Vincenzi, Paola De Luca, Enrico Ragni, Marco Viganò, Stefania Setti, Katia Varani, Laura de Girolamo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. ChronicJournal of clinical medicine · 2024
    Article
  5. Article
  6. Adenosine AFrontiers in pharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alessandra ColombiniOrthopaedic Biotechnology Lab, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.ORCID 0000-0002-1800-3424
Carlotta Perucca OrfeiOrthopaedic Biotechnology Lab, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Fabrizio VincenziDepartment of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Paola De LucaOrthopaedic Biotechnology Lab, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Enrico RagniOrthopaedic Biotechnology Lab, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Marco ViganòOrthopaedic Biotechnology Lab, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Stefania SettiIGEA SpA, Carpi, Modena, Italy.
Katia VaraniDepartment of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Laura de GirolamoOrthopaedic Biotechnology Lab, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Istituto Ortopedico Galeazzi · ITUniversity of Ferrara · ITInterventi Geo Ambientali (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tendinopathy is a degenerative disease in which inflammatory mediators have been found to be sometimes present. The interaction between inflammation and matrix remodeling in human tendon cells (TCs) is supported by the secretion of cytokines such as IL-1β, IL-6 and IL-33. In this context, it has been demonstrated that pulsed electromagnetic fields (PEMFs) were able to reduce inflammation and promote tendon marker synthesis. The aim of this study was to evaluate the anabolic and anti-inflammatory PEMF-mediated response on TCs in an in vitro model of inflammation. Moreover, since PEMFs enhance the anti-inflammatory efficacy of adenosine through the adenosine receptors (ARs), the study also focused on the role of A2AARs. Human TCs were exposed to PEMFs for 48 hours. After stimulation, A2AAR saturation binding experiments were performed. Along with 48 hours PEMF stimulation, TCs were treated with IL-1β and A2AAR agonist CGS-21680. IL-1Ra, IL-6, IL-8, IL-10, IL-33, VEGF, TGF-β1, PGE2 release and SCX, COL1A1, COL3A1, ADORA2A expression were quantified. PEMFs exerted A2AAR modulation on TCs and promoted COL3A1 upregulation and IL-33 secretion. In presence of IL-1β, TCs showed an upregulation of ADORA2A, SCX and COL3A1 expression and an increase of IL-6, IL-8, PGE2 and VEGF secretion. After PEMF and IL-1β exposure, IL-33 was upregulated, whereas IL-6, PGE2 and ADORA2A were downregulated. These findings demonstrated that A2AARs have a role in the promotion of the TC anabolic/reparative response to PEMFs and to IL-1β.

Indexed as

Electromagnetic FieldsAdenosine A2 Receptor AgonistsBasic Helix-Loop-Helix ProteinsCells, CulturedCollagen Type IIICytokinesDown-RegulationHumansInterleukin-1betaInterleukin-33Interleukin-6Receptor, Adenosine A2ATendonsUp-RegulationAdenosine A2 Receptor AgonistsADORA2A protein, humanBasic Helix-Loop-Helix ProteinsCOL3A1 protein, humanCollagen Type IIICytokinesInterleukin-1betaInterleukin-33Interleukin-6Receptor, Adenosine A2ASCX protein, human

Identifiers

PMID32998161
PMCPMC7527253
OpenAlexW3089356945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.